Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Location: St Louis MO, Kansas City MO, Louisville KY,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 30
Code: NCT06541262
Phase1, Phase2, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: St Louis MO, Springfield IL, Columbia MO, Peoria IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
for
Medulloblastoma
Location: St Louis MO, Kansas City MO, Louisville KY, Chicago IL,
Sponsor: Giselle Sholler
Sex: All
Age: 0 - 21
Code: NCT04696029
Phase2, Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
for
Atypical Teratoid/Rhabdoid Tumor,
Location: St Louis MO, Kansas City KS, Nashville TN,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 26
Code: NCT06465199
Phase1, Phase2, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St Louis MO, Peoria IL, Iowa City IA, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: St Louis MO, Peoria IL, Iowa City IA, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: St Louis MO, Peoria IL, Iowa City IA, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Center for International Blood and Marrow Transplant Research
Location: St Louis MO, Springfield IL, Columbia MO, Peoria IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: St Louis MO, Springfield IL, Peoria IL, Iowa City IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study